News Archive: Policy

On 25 September 2015, the leaders of the 193 United Nations (UN) Member Countries endorsed a resolution outlining an ambitious set of goals and targets to be fulfilled by 2030. Amongst these targets featured universal health coverage (UHC) for all (Goal 3, Target 3.8). IAPO believes that adequate...
El resumen de políticas de este mes explora el tema del empoderamiento del paciente como preparación del Día de Solidaridad con el Paciente de este año pero esta vez, enfocado en el papel del empoderamiento del paciente cuando los pacientes participan en investigación. Para que exista realmente una...
El resumen de políticas de este mes se enfoca en el empoderamiento de los pacientes, un tema que apoya al plan de compromiso y empoderamiento 2017 de IAPO IAPO’s 2017 engagement and empowerment plan y que además es el tema del Día de Solidaridad con el Paciente de este año ( PSD ), el cual se...
El 4 th – 5 th de julio 2017, IAPO celebró su 3 ra Reunión Regional Africana. Fue una oportunidad para que la comunidad de los miembros africanos de IAPO se reunieran y instaran a la creación de la Agencia Africana de Medicamentos centrada en los pacientes. En este sentido, se hizo énfasis en la...
El Resumen de este mes está enfocado en la seguridad del paciente. La seguridad del paciente está estrechamente unida con el segundo tema clave del plan de empoderamiento y compromiso lanzado en el 2017 por IAPO: El acceso. Por otra parte, la seguridad del paciente representa por si sola una de las...
The long wait is over: Tedros Adhanom Ghebreyesus has been elected as the World Health Organization’s new director-general by the World Health Assembly. The former minister of health of Ethiopia beat two other finalists in the race — the U.K.’s David Nabarro and Pakistan’s Sania Nishtar — with a...
The week long hard intense debates on global health at the 70th World Health Assembly in Geneva came to an end on 31 st May 2017. The slow slog of the debates inside the Assembly Hall was a contrast to fast-paced side-events and discussions being held by non-State Actors. Issues were not just...
El resumen de políticas de este mes está enfocado en la participación de los pacientes en la evaluación de la tecnología sanitaria (HTA). Este tópico cae dentro del segundo tema clave de IAPO 2017 – Plan de empoderamiento y compromiso 2017 ( 2017 engagement and empowerment plan ): Acceso. Existe...
Dr. Matthias Wienold , our board member and Treasurer, attended the high profile 2nd Global Ministerial Summit on Patient Safety in Bonn in March 2017 and reports back on the launch of the 3rd Global Patients Safety Challenge: Medication Without Harm. IAPO and its members will support this campaign over the coming years.
El resumen de políticas de este mes está centrado en el acceso que es el segundo “tema clave” del plan de compromiso y empoderamiento 2017 ( 2017 engagement and empowerment plan ). El acceso y el apoyo también figuran entre los cinco principios de la Declaración de la IAPO sobre la asistencia...
El resumen de políticas de este mes está centrado en la información del paciente. La información del paciente es uno de los pilares sobre los cuales se fundamenta el concepto de asistencia sanitaria centrada en el paciente. Cuando la información es exacta, completa y fácil de entender los pacientes pueden fortalecer su conocimiento sobre los procesos sanitarios y sus mecanismos.
The International Conference of Drug Regulatory Authorities (ICDRA) is an annual event hosted for the benefit of the WHO Member States and their national medicines regulatory authorities (NMRAs); many non-State actors attend a pre-ICDRA conference to share their views with NMRAs. The 17th pre-ICDRA...
UK Supreme Court (UKSC) judgment in Montgomery v Lanarkshire Health Board has closed the gap between ‘legal consent’, ‘informed consent’ and the ‘best interest’ of the patients. The full judgment, the point of law decided and the rationale for the decision (ratio decidendi) of this important case...
WHO World Health Assembly (May 2016), WHO Regional Committee Meetings (Sep-Oct 2016) and the UN General Assembly Debate (Sep 2016) had great discussions on SDG 2030, UHC and health workforce strengthening. Kawaldip Sehmi, our CEO, has assembled critical thinking on this matter of some of the '...
Dr. Matthias Wienold (IAPO Treasurer and Board Member) and Stijntje Dijk (Liaison Officer International Federation of Medical Students Associations (IFMSA) ) Stijntje, whom you all met at our Global Patients Congress 2016, and I held a joint workshop at the Association for Medical Education in...
Board member Hussain Jafri reporting from the multi-stakeholder hearing of the UN General Assembly High-Level Summit on migrants and refugees 18-22 July 2016, United Nations, New York The most vulnerable patients in the world From the jungles of Central America, deserts of North Africa to the...
La corrupción en el sector de la salud puede hacer la diferencia entre la vida y la muerte, y a menudo son las personas más pobres del mundo las que son afectadas más.
A group of 18 leading biopharmaceutical companies have come together share ideas, simplify and speed up the research and development of new drugs, and improve patient experience around the globe.
Antonio Ciaglia, el Director de Política de IAPO, explora por qué la confianza debe ser el núcleo de las relaciones entre doctores y pacientes, y cómo esto debería ser un pilar fundamental de la asistencia sanitaria centrada en el paciente.
Muchas de las estrategias de abogacía del paciente e intervenciones usadas hoy en día fueron inicialmente desarrolladas en el Distrito Castro en San Francisco, California, EEUU, en los años ochenta. Hoy en día una enorme bandera con los colores del arco iris ondea orgullosa sobre El Castro, proclamando su confianza, vitalidad y espíritu comunitario.
In the 1980s, the Castro District of San Francisco was under attack from an unknown and devastating disease that was killing its young men, and attacked by the media, politicians and society that forced it to the brink of collapse.
Since the 7th Global Patients Congress in April, IAPO CEO Kawaldip Sehmi and Board Member Matthias Wienold have written several blogs for the world-renowned British Medical Journal.
World Health Assembly, 23-28 May 2016. IAPO held three side meetings and addressed the Assembly on three pressing patient issues: large scale emergencies, health of migrants and primary care.
Once again, the global health policy elites will meet at the 69th World Health Assembly in Geneva from 23 to 28 May 2016.
IAPO Policy Manager Alison Lightbourne recently explored how to build a better care continuum for the Healthmanagement.org journal.
Happy Birthday to the World Health Organization (WHO)! 7 April will mark the 68 th year since WHO was formed in 1948, and this day is celebrated as World Health Day each year.
IAPO will be attending the 69th session of the World Health Organization's (WHO) World Health Assembly (WHA) meeting in Geneva from 23-28 May 2016.
On 7 March 2016, the European Medicines Agency (EMA) launched PRIME : Priority Medicines. PRIME is a new scheme that will provide scientific and regulatory support to researchers and medicine developers with the aim of benefitting patients without treatment options or “unmet medical needs”.
A brief look at universal health coverage examples in the UK and Thailand.
Mental health advocates have been surprised by two reviews of mental health services arriving at the same time.
The World Health Organization (WHO) held the first of its twice-yearly Executive Board meetings for 2016 at the end of January.
Dicen que en el pasado, los gobiernos evitaban el escrutinio internacional sobre sus políticas nacionales de salud, aduciendo defensa de la soberanía. Las cosas han cambiado en los últimos quince años, de tal manera que la gobernanza de salud global, comienza a sentar raíces.
This year's Congress will focus on 'innovation improving sustainable access: how to boost your reach and impact'.
Dando la bienvenida a un nuevo año a menudo trae reflexión en nuestras vidas personales y profesionales cuando pensamos a lo que viene y los cambios que queremos hacer.
Un juez dictaminó que una hija puede consentir a rehusar tratamiento en el nombre de su madre en ‘estado vegetativo’.
En el 25-30 de enero del 2016, la reunión del consejo directivo a la Organización Mundial de la Salud (OMS) tendrá lugar en Ginebra.
Un grupo de científicos ha lanzado un proyecto de colaboración abierta distribuida para financiar investigación sobre el uso de medicamentos contra la malaria para tratar el cáncer colorrectal.
Las representantes de IAPO Eva Maria Ruiz de Castilla y Maria Julia Muñoz Serrano asistieron a la reunion del comité regional de las Américas de la OMS , en Washington DC, desde el 28 Septiembre al 2 de Octubre. Por Maria Julia Muñoz Serrano.​
Durante el mes pasado, los representantes de IAPO asistieron a las reuniones regionales de la Organización Mundial de la Salud en los EE.UU., Guam y Kuwait.​
Written by Jolanta Bilińska, IAPO Chair. I attended the 62nd session of the World Health Organization (WHO) Regional Committee for the Eastern Mediterranean from 5-8 October 2015.
IAPO members Karen Alparce-Villanueva and KP Tsang attend the WHO WPRO meeting on behalf of IAPO.
The WHO and UNAIDS have launched 'global standards for quality health-care services for adolescents'.
The Sustainable Development Goals were launched at the end of September and the specific health targets have been revealed.
IAPO tiene el placer de dar la bienvenida a Antonio Ciaglia como nuestro nuevo Oficial de Política e Investigación. Antonio principalmente trabajará con el proyecto ‘Get Real’.
IAPO CEO Kawaldip Sehmi recently wrote a guest editorial on 'Patient Power' for the HealthManagement.org Journal.
IAPO representatives Eva Maria Ruiz de Castilla and Maria Julia Muñoz Serrano are attending the WHO Americas regional committee meeting, taking place in Washington DC from 28 September to 2 October. Interventions Our representatives delivered interventions on Strategy on Health-related Law and...
Most of us have come into contact with healthcare systems whether as a patient, a family member, a health professional, a policy-maker or other. The building and fostering of relationships between all health stakeholders can help to ensure improved safety and quality of care.
Transparency in how decisions are made and the interactions between the pharmaceutical industry and the patient community is crucial to building trust and openness, and every stakeholder must play their part.
Three organizations have developed a survey to improve patient experience in clinical trials. Have your say.
A joint intervention delivered at the WHO's EURO Regional Committee meeting, 15 September 2015.
El involucramiento de los pacientes y de las personas en la atención sanitaria – ¿qué significa? ¿Qué lo hace significativo?
17 goals, 169 targets, 15 years, 193 member states: an introduction to the sustainable development goals and where health fits in.
When Friedrich Nietzsche said, ‘That which does not kill us makes us stronger’, he had no idea that what was true for humans was also true for microbes!
Alison Lightbourne, IAPO Policy Manager, shares on how to get the message across and the importance of communicating clearly.
Two charities recently won a landmark case in the UK Supreme Court that will change the health and social welfare laws which affect thousands of children with severe chronic health conditions.
Bill and Melinda Gates Foundation ( BMGF ) is currently consulting with health advocates and key civil society organizations on the launching of a new initiative aimed at building high-performing health care systems in the 21st century.
The WHO has released a global strategy on people-centred and integrated health services (PCIHS) and it is now open for public consultation. Dr Edward Kelley, from Service and Delivery at the WHO, has written the invitation below.
IAPO CEO Kawaldip Sehmi explores how using a human rights-based approach (HRBA) can be a powerful factor in achieving patient-centred healthcare as patient advocates can now go beyond their national constitutions, statutory law (Acts of Parliament) and subsidiary legislation to seek help from international law. They can invite global health governance scrutiny on the actions and inactions of their national governments and their health systems.
Alison Lightbourne, IAPO Policy Manager, explores the risks of looking at health problems with a narrow focus and the impact this can have on the lives of patients.
In support of the 'SAVE LIVES: Clean Your Hands' campaign on 5 May and ten years of the 'WHO Clean Care is Safer Care' programme, the 2nd WHO Hand Hygiene Self-Assessment Framework Global Survey was launched on 1 June 2015 and will be open until 10 September 2015.
Kawaldip Sehmi, IAPO's Chief Executive Officer, explores the importance of naming diseases and conditions in a patient-centred way.
The World Health Assembly (WHA) was held last week in Geneva, Switzerland, at the Palais des Nations, a fitting venue for such a large-scale gathering that brings together people from around the world representing countries, non-governmental groups, commercial and professional interests.
WHO: Is it sufficient to treat an illness without knowing and addressing the conditions that cause or contribute to individuals becoming sick in the first place?
Why should health professionals know about the conditions in which you live? By Sir Michael Marmot, Director of the UCL Institute of Health Equity and President-Elect of the World Medical Association
La gerente de políticas de IAPO, Alison Lightbourne explora la importancia de la higiene de manos y si sigue siendo un problema acuciante en el mundo de hoy.
Esta semana la Organización Mundial de la Salud (OMS) lanzó una nueva estrategia y campaña global para la seguridad de las inyecciones.
The importance of universal health coverage and the need for transparency at the World Health Organization's Executive Board meeting, January 2015.
The IAPO Governing Board recently signed up to several collaborative campaigns and our universal health coverage principles are now available.
Over the last few months, IAPO has been working on a new strategic plan for 2015 to 2017. Our key theme is universal health coverage.
KP Tsang, IAPO Chair, and John Forman, from IAPO member NZ Organisation for Rare Disorders, attended the WHO Regional Committee meeting for Western Pacific from 13 to 17 October in Manila, Philippines. John answered a few questions about the meeting. In what ways did you represent IAPO at your WHO...
Eva Maria Ruiz de Castilla, IAPO Secretary, and Piga Fernández, from IAPO member Fundación GIST Chile, attended the WHO Regional Committee meeting for the Americas in Washington DC, USA, from 29 September to 3 October. Piga answered a few questions about the meeting. In what ways did you represent...
In October 2014, IAPO Policy Manager Alison Lightbourne attended a meeting to discuss health technology assessment (HTA) and how it will help or limit patient access to new medicines and treatment. HTA is quickly evolving into a global issue and is now featured within the World Health Organisation...
Jolanta Bilinska, IAPO Chair Elect, and Evgenia Starkova, from IAPO member Together Against Cancer, attended the WHO Regional Committee meeting for Europe in Copenhagen, Denmark from 15 to 18 September 2014. In what ways did you represent IAPO at your WHO Regional Committee? We shared two...
Las Reuniones del Comité Regional 2014 de la Organización Mundial de la Salud (OMS) 2014 están en marcha. Estas buscan fijar políticas, aprobar presupuestos y decidir los programas de trabajo para cada una de las regiones de la OMS.. Representantes de IAPO asistieron las semanas anteriores a...
We are in the final stages of confirming a set of principles that will underpin IAPO’s work and support member advocacy on universal health coverage (UHC). Members played a key role in drafting these principles at the IAPO Congress in March and in the months since. Delivering universal health...
IAPO Governing Board Member Eva Maria Ruiz de Castilla recently attended two UN meetings on non-communicable diseases (NCDs). An informal interactive meeting for civil society was held on 19 June 2014 to discuss progress in NCD work since 2011 and to identify priorities going forward.
IAPO member Theobald Hepatitis B Foundation, along with partners, offered free hepatitis B screening and vaccination to hundreds of people at James Town – Mantse Abgona in Accra, Ghana, on 26 July 2014.
In June 2014, our Senior Policy Officer Rachel Seal-Jones spoke to new IAPO member Powerful Patient through a podcast. Powerful Patient is based in the United States and works to empower people living with chronic diseases or disabilities.
Tuesday 21st January 2014 - 134th Session of the World Health Organization's Executive Board, Geneva. IAPO delivered an intervention on Agenda Item 7.1: Follow up to the Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. IAPO called on Member States to develop national action plans to ensure that progress is sustained at the national level, as well as highlighting the importance of patients being at the centre of all NCD strategies.